Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu, Yi Duan, Ling Yang, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 359-370
Open Access | Times Cited: 304

Showing 26-50 of 304 citing articles:

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 44
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Yuhang Du, Changhao He, Yongcheng An, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7379-7379
Open Access | Times Cited: 30
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function
Fabian Frost, Tim Kacprowski, Malte Rühlemann, et al.
Gut (2020) Vol. 70, Iss. 3, pp. 522-530
Open Access | Times Cited: 129
Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice
Chihiro Ushiroda, Yuji Naito, Tomohisa Takagi, et al.
Journal of Clinical Biochemistry and Nutrition (2019) Vol. 65, Iss. 1, pp. 34-46
Open Access | Times Cited: 127
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 2, pp. 163-177
Open Access | Times Cited: 126
Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
Toon J. I. De Munck, Pan Xu, Harm J. A. Verwijs, et al.
Liver International (2020) Vol. 40, Iss. 12, pp. 2906-2916
Open Access | Times Cited: 101
Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system
Mengting Chen, Pengfei Hou, Min Zhou, et al.
Clinical Nutrition (2019) Vol. 39, Iss. 4, pp. 1264-1275
Closed Access | Times Cited: 99
The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
Julio Plaza‐Díaz, Patricio Solis‐Urra, Fernando Rodríguez‐Rodríguez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8351-8351
Open Access | Times Cited: 97
Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
Caroline C. Duwaerts, Jacquelyn J. Maher
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 7, Iss. 4, pp. 749-761
Open Access | Times Cited: 89
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Han, Yi Jiang, Mengyu Wang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 12, pp. 1689-1706
Closed Access | Times Cited: 87
Enteric dysbiosis is associated with sepsis in patients
Zhanguo Liu, Na Li, Heng Fang, et al.
The FASEB Journal (2019) Vol. 33, Iss. 11, pp. 12299-12310
Open Access | Times Cited: 85
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis – Part 2: Acetate and ACSS2 in Health and Disease
John R. Moffett, Narayanan Puthillathu, Ranjini Vengilote, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 80
Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota
Wenlong Sun, Xinyu Li, Hao-Yue Dou, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109641-109641
Open Access | Times Cited: 79
Microbial metabolites in non-alcoholic fatty liver disease
Da Zhou, Jian‐Gao Fan
World Journal of Gastroenterology (2019) Vol. 25, Iss. 17, pp. 2019-2028
Open Access | Times Cited: 78
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota
Naoko Ohtani, Eiji Hara
Cancer Science (2021) Vol. 112, Iss. 11, pp. 4433-4443
Open Access | Times Cited: 76
MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis
Xu Wang, Linlin Shi, Xinping Wang, et al.
International Journal of Biological Macromolecules (2019) Vol. 141, pp. 1013-1021
Closed Access | Times Cited: 75
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Marco Arrese, Juan Pablo Arab, Francisco Barrera, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 04, pp. 421-434
Open Access | Times Cited: 75
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis
Qiaoyan Liu, Bo Li, Yikang Li, et al.
Gut (2021) Vol. 71, Iss. 5, pp. 899-909
Closed Access | Times Cited: 71
Polystyrene microplastics impact the occurrence of antibiotic resistance genes in earthworms by size-dependent toxic effects
Guanghui Xu, Yong Yu
Journal of Hazardous Materials (2021) Vol. 416, pp. 125847-125847
Closed Access | Times Cited: 65
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 64
Machine learning for data integration in human gut microbiome
Peishun Li, Hao Luo, Boyang Ji, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool
Ambrin Farizah Babu, Susanne Csader, Ville Männistö, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Yue Shen, Shengdi Wu, Yao Chen, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 43
Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut
Kyung Hyun Kim, Dongbin Park, Baolei Jia, et al.
mSystems (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 38
Effects of thiacloprid exposure on microbiota–gut–liver axis: Multiomics mechanistic analysis in Japanese quails
Biqi Han, Jiayi Li, Siyu Li, et al.
Journal of Hazardous Materials (2022) Vol. 442, pp. 130082-130082
Closed Access | Times Cited: 38

Scroll to top